Zimmer Biomet Holdings Total Assets 2006-2018 | ZBH

Zimmer Biomet Holdings total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Zimmer Biomet Holdings total assets for the quarter ending December 31, 2018 were $24.127B, a 7.25% decline year-over-year.
  • Zimmer Biomet Holdings total assets for 2018 were $24.127B, a 7.25% decline from 2017.
  • Zimmer Biomet Holdings total assets for 2017 were $26.014B, a 2.51% decline from 2016.
  • Zimmer Biomet Holdings total assets for 2016 were $26.684B, a 1.75% decline from 2015.
Zimmer Biomet Holdings Annual Total Assets
(Millions of US $)
2018 $24,127
2017 $26,014
2016 $26,684
2015 $27,161
2014 $9,658
2013 $9,581
2012 $9,012
2011 $8,515
2010 $8,000
2009 $7,786
2008 $7,239
2007 $6,634
2006 $5,974
2005 $5,722
Zimmer Biomet Holdings Quarterly Total Assets
(Millions of US $)
Q4 2018 $24,127
Q3 2018 $25,382
Q2 2018 $25,491
Q1 2018 $27,181
Q4 2017 $26,014
Q3 2017 $26,418
Q2 2017 $26,459
Q1 2017 $26,988
Q4 2016 $26,684
Q3 2016 $27,037
Q2 2016 $25,971
Q1 2016 $26,297
Q4 2015 $27,161
Q3 2015 $26,689
Q2 2015 $27,204
Q1 2015 $17,190
Q4 2014 $9,658
Q3 2014 $9,671
Q2 2014 $9,638
Q1 2014 $9,380
Q4 2013 $9,581
Q3 2013 $9,357
Q2 2013 $9,097
Q1 2013 $8,745
Q4 2012 $9,012
Q3 2012 $8,784
Q2 2012 $8,617
Q1 2012 $8,604
Q4 2011 $8,515
Q3 2011 $8,199
Q2 2011 $8,249
Q1 2011 $8,118
Q4 2010 $8,000
Q3 2010 $8,004
Q2 2010 $7,827
Q1 2010 $7,822
Q4 2009 $7,786
Q3 2009 $7,648
Q2 2009 $7,462
Q1 2009 $7,232
Q4 2008 $7,239
Q3 2008 $7,079
Q2 2008 $6,942
Q1 2008 $6,919
Q4 2007 $6,634
Q3 2007 $6,367
Q2 2007 $6,321
Q1 2007 $6,098
Q4 2006 $5,974
Q3 2006 $5,909
Q2 2006 $5,964
Q1 2006 $5,917
Q4 2005 $5,722
Q3 2005 $5,622
Q2 2005 $5,552
Q1 2005 $5,591
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.620B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Stryker (SYK) United States $72.140B 26.48
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
GW Pharmaceuticals (GWPH) United Kingdom $5.086B 0.00
ICU Medical (ICUI) United States $4.899B 30.50
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Quidel (QDEL) United States $2.668B 24.07
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14